Prescribing practices and use of opioid analgesics: a sociological analysis
In a glimpse, OFDT, 2 p.
August 2023
The study on the use of analgesic opioid medicines (EMOA) by the French Monitoring Centre for Drugs and Drug Addiction (OFDT) examines their prescription in general practice and the experiences of who consider themselves to be having difficulty with them in the treatment of chronic pain unrelated to cancer in France. Based mainly on in-depth interviews with 23 general practitioners (GPs) and 25 patients, it analyses, on the one hand, prescribing practices, by examining the decision to prescribe (and deprescribe) opioid analgesics and, on the other hand, patients’ medication pathways, by examining the place of these drugs in their life and health trajectories. This research analyses the difficulties encountered by doctors in the prescribing process (particularly in stopping or continuing prescriptions when they are not responsible for initiating them), and those associated with prolonged, regular, or recurrent use by patients.
Download In a glimpse, prescribing practices and use of opioid analgesics: a sociological analysis (290 Ko, 2p.)
Drugs in Europe
2023 EMCDDA European Drug Report
The European Drug Report 2023: Trends and Developments presents the EMCDDA’s latest analysis of the drug situation in Europe. Focusing on illicit drug use, related harms and drug supply, the report contains a comprehensive set of national data across these themes and key harm-reduction interventions. This report is based on information provided to the EMCDDA by the EU Member States, the candidate country Türkiye, and Norway, in an annual reporting process.
The annual Statistical Bulletin contains the most recent available data on the drug situation in Europe provided by the Member States. These datasets underpin the analysis presented in the European Drug Report. All data may be viewed interactively on screen and downloaded in Excel format.
The European Union and the drug phenomenon
The European Union & the drug phenomenon : Frequently asked questions, joint publication between the EMCDDA and the European Commission, october 2010, 12 p.
